"Abstract 329: Potential Role of Enrichment Strategies with CAC Testing for Future Clinical Trials Assessing PCSK-9 Inhibitors Efficacy Among Diabetics Without Established Cardiovascular Disease" by Khurram Nasir

Article

Abstract 329: Potential Role of Enrichment Strategies with CAC Testing for Future Clinical Trials Assessing PCSK-9 Inhibitors Efficacy Among Diabetics Without Established Cardiovascular Disease

Circulation-cardiovascular Quality and Outcomes (2015)

Khurram Nasir, Johns Hopkins University
Marcio BittenCourt, University of São Paulo
Ron Blanskstein, Brigham and Women's Hospital
Michael Blaha, Johns Hopkins University
Emir Veledar, Emory University

Link

Disciplines

Medicine and Health Sciences,
Emergency Medicine and
Endocrinology, Diabetes, and Metabolism

Publication Date

May 1, 2015

Citation Information

Khurram Nasir, Marcio BittenCourt, Ron Blanskstein, Michael Blaha, et al.. "Abstract 329: Potential Role of Enrichment Strategies with CAC Testing for Future Clinical Trials Assessing PCSK-9 Inhibitors Efficacy Among Diabetics Without Established Cardiovascular Disease" Circulation-cardiovascular Quality and Outcomes Vol. 8 Iss. 2 (2015)
Available at: http://works.bepress.com/emir-veledar/193/